Camden Capital, LLC Abb Vie Inc. Transaction History

Camden Capital, LLC

$896 Million
Q3 2024

A detailed history of Camden Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Camden Capital, LLC holds 6,546 shares of ABBV stock, worth $1.12 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

6,546

Previous 6,775 3.38%

Holding current value

$1.12 Million

Previous $1.16 Million 11.19%

% of portfolio

0.14%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $37,519 - $45,646	-229 Reduced 3.38%	6,546 $1.29 Million
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $95,195 - $111,167	615 Added 9.98%	6,775 $1.16 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $442,381 - $504,052	-2,768 Reduced 31.0%	6,160 $1.12 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $550,262 - $619,725	3,999 Added 81.13%	8,928 $1.38 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $14,427 - $16,702	108 Added 2.24%	4,929 $734,000
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $27,959 - $34,793	211 Added 4.58%	4,821 $649,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $59,000 - $67,948	408 Added 9.71%	4,610 $734,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $660,845 - $792,526	-4,778 Reduced 53.21%	4,202 $679,000
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $786,336 - $901,875	5,859 Added 187.73%	8,980 $1.21 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $117,940 - $149,940	-857 Reduced 21.54%	3,121 $478,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $22,172 - $27,510	-168 Reduced 4.05%	3,978 $645,000
Q4 2021 Feb 28, 2022	SELL	$107.43 - $135.93 $432,083 - $546,710	-4,022 Reduced 49.24%	4,146 $561,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $67,143 - $84,956	-625 Reduced 7.11%	8,168 $1.11 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $4,468 - $5,072	-42 Reduced 0.48%	8,793 $949,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $61,442 - $68,450	584 Added 7.08%	8,835 $995,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $353,139 - $388,764	3,452 Added 71.93%	8,251 $893,000
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $46,281 - $62,485	575 Added 13.61%	4,799 $514,000
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $49,741 - $58,380	579 Added 15.88%	4,224 $370,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $267,433 - $357,866	3,645 New	3,645 $358,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Abb Vie Inc. Transaction History